Markwin Velders
InvestorAdvisory Committee member at Curie Capital
Hilversum, North Holland, Netherlands
Find your path to Markwin
184 people in our graph share verified history with Markwin — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedMarkwin: together at Oncode Institute (2020–2023)
×5Markwin: together at Leiden University
×2Markwin: together at Kite Pharma
Markwin: together at TNO
About
Advisory Committee member and seasoned biotech leader; holds a PhD.
Experience
- Prime Life Science BVManaging Director and Ownercurrent2020 — presentHilversum, Noord-Holland, Nederland
- Amarna Therapeutics B.V.Member of the Supervisory Boardcurrent2020 — presentLeiden, Zuid-Holland, Nederland
- Thuja CapitalAdvisory Board Membercurrent2021 — presentUtrecht, Nederland
- NECSTGENAdvisory Board Membercurrent2021 — presentLeiden, Zuid-Holland, Nederland
- ISA PharmaceuticalsMember Of The Supervisory Board2019 — 2024Leiden
- Oncode InstituteEntrepreneur In Residence2020 — 2023Utrecht, Nederland
- HollandBIOChairman Of The Board2017 — 2021
- HollandBIOBoard member2016 — 2021Den Haag en omgeving, Nederland
- Kite PharmaVP Operations2015 — 2020Amsterdam Area, Netherlands
- SomantiX BVChief Executive Officer2013 — 2015Utrecht Area, Netherlands
- T-Cell FactoryBusiness Development Consultant2013 — 2015Amsterdam Area, Netherlands
- Prime Life ScienceManaging Director and Owner2011 — 2015
- Institute QuantivisionManaging Director a.i.2012 — 2014Amsterdam Area, Netherlands
- TropIQDirector Business Development2012 — 2013Nijmegen Area, Netherlands
- TNOBusiness Unit Manager2009 — 2011
- TNOManager Operations TNO Biosciences2008 — 2011
- AM-PharmaVP R&D/CSO2005 — 2008
- CentocorQC consultant2004 — 2005
- Arrante BVManager application and product development2003 — 2004
- Glaucus ProteomicsDirector Immunology2002
- Loyola University Medical CenterAssistant Professor1999 — 2002
- Loyola University Medical CenterPost Doc1996 — 1999
- LUMCPhD student1990 — 1996
- Centocor MalvernTrainee1993 — 1994
Skills & more
Lifesciences39Biotechnology31R&D19Start-ups17Immunology15Molecular Biology12Vaccines8Entrepreneurship5Cell Culture7Science6Drug Discovery5Business Development4
+12 more
Protein ChemistryLife SciencesOncologyCancerGeneticsStrategyBiopharmaceuticalsInnovation ManagementValidationBusiness StrategyAssay DevelopmentGMPLanguages English
From Markwin's professional profile.
Colleagues at Curie Capital
Han de Groot
Partner at VOC Capital Partners B.V.
Helmuth van Es
Advisory Committee member at Curie Capital
Mariette van der Velden
Partner at Curie Capital
Minh Thu Nguyen
Fellow at Curie Capital
Mirjam Mol-Arts
Advisory Committee member at Curie Capital
Olivier Tak
Junior Partner at Curie Capital
Thom Frielink
Associate at Curie Capital
Frequently asked questions
- Who is Markwin Velders?
- Advisory Committee member and seasoned biotech leader; holds a PhD.
- Where does Markwin Velders work?
- Markwin Velders is Advisory Committee member at Curie Capital.
- Where did Markwin Velders go to school?
- Markwin Velders studied at Leiden University (PhD, Molecular Immunology); Leiden University (Master of Science - MS, Biomedical Sciences); Weizmann Institute of Science (Zelig Eshhar lab/chimeric TCR/CAR-T, Molecular Immunology).
Same school
Also attended Leiden University119
Andrea van ElsasInvestor at Third Rock VenturesJoost HollemanInvestor at Prime VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at Syncona
+ 113 more
Shared employers
Also worked at Oncode Institute6
René KuijtenInvestor at LSP (Life Sciences Partners)Teri WilleyP2C Managing Director & Officer at Pathway to CuresRudy DekeyserPartner, Head of Health Economic Funds at EQT Life SciencesRene KuijtenHead of EQT Life Sciences at EQT Life SciencesJanine SchuurmanSenior Advisor at Bioqube VenturesRudy DekeyserGeneral Partner at EQT Health Economics Cooperatief
